9 results for "A. D. Gvozdeva"
Showing 1–9 · 0.75 seconds · RSS
-
Journal Article
Socio-economic burden of pulmonary hypertension: relevance of assessment in Russia and the world
Pulmonary hypertension (PH) is a progressive disease which is characterized with the increase of pulmonary artery pressure and pulmonary vascular resistance. Such condition leads to right ventricular heart failure and premature death of patients. Pulmonary arterial hypertension (PAH) has the status…
-
Journal Article
Heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus: pathophysiology and treatment options
Type 2 diabetes mellitus is known to increase the risk of the development of heart failure with preserved ejection fraction and worsen its symptoms. To date, no specific treatment has been shown to reduce morbidity and mortality in patients with heart failure with preserved ejection fraction. In…
-
Journal Article
Outcome of art programs for patients with habitable inequality of pregnancy in anamnesis
The aim of the study was to assess the effectiveness of auxiliary reproductive technologies (ART) programs in patients with a habitual miscarriage (HM) in an anamnesis. Materials and methods. A prospective cohort study included 200 patients with infertility, 100 of whom had a history of HM (2 or…
-
Journal Article
Predictors of unfavorable progression and prognosis in patients with heart failure with preserved left ventricular ejection fraction
Heart failure with preserved ejection fraction (HFpEF) is the most common form of heart failure (HF) worldwide and is characterized by a severe course, poor prognosis, and limited effective treatments. To date, there are no reliable prognostic algorithms to identify high-risk patients, and…
-
Journal Article
Lipitension today — disaster tomorrow: focus on elderly comorbid patients
In elderly and senile patients, a combination of hypertension and atherogenic dyslipidemia is often encountered, which, both separately and in combination ("lipitension"), are associated with a high risk of cardiovascular events. In clinical practice, it is not just the age itself that is…
-
Journal Article
Potential of valsartan+sacubitril therapy in hypertensive heart disease
The course of hypertension is often complicated by left ventricular hypertrophy (or hypertensive heart disease, HHD). The main “corridor” of natural HHD is development of heart failure with preserved ejection fraction (HFpEF). With HFpEF, the bioavailability of natriuretic peptides (NP) is…
-
Journal Article
Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
Chronic heart failure (CHF) is a complex clinical syndrome characterized by poor prognosis. According to the Russian epidemiological study EPOHA-CHF, more than half of patients with CHF have preserved left ventricular ejection fraction (LV EF). However, no class of drugs has proven effectiveness in…
-
Journal Article
Case report of atypical takotsubo cardiomyopathy complicated by cardiogenic shock
Introduction. The diffuse form of takotsubo cardiomyopathy is extremely rare and even less frequently differentiated from other syndromes. Nevertheless, prompt identification of this condition and a correct emergency care protocol will facilitate proper treatment and minimize…
-
Journal Article
Effects of empagliflozin on exercise tolerance and left ventricular diastolic function in patients with heart failure with preserved ejection fraction and type 2 diabetes: a prospective single-center study
Aim. To assess the effect of the sodium-glucose transport protein 2 inhibitor empagliflozin on exercise tolerance and left ventricular (LV) diastolic function in patients with heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes (T2D).Material and methods. The present…